Consistent with prior reports, DTX and ATRA have been shown to act synergistically to induce apoptosis in DU-145 prostate cancer cells through downregulation of pro-survival genes such as survivin, MCL-1 and LTβR, which are critically involved in apoptosis regulation and cell-cycle control24. This evidence concerns the gene MCL1 and prostate carcinoma.